{
    "2018-12-25": [
        [
            {
                "time": "",
                "original_text": "大额回购+业绩预喜，这些超跌股已获北上资金“举牌” 盈利能力下降",
                "features": {
                    "keywords": [
                        "大额回购",
                        "业绩预喜",
                        "超跌股",
                        "北上资金",
                        "举牌",
                        "盈利能力下降"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "股票市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英：带量采购将助推CDMO市场壮大",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "带量采购",
                        "CDMO",
                        "市场壮大"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药行业",
                        "CDMO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "(互动)凯莱英：带量采购会促进仿制药企业转型升级和推出创新品种",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "带量采购",
                        "仿制药",
                        "转型升级",
                        "创新品种"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药行业",
                        "仿制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报2018第46期:DRGs试点即将启动,精细化管理将利好进口替代",
                "features": {
                    "keywords": [
                        "医药行业",
                        "DRGs试点",
                        "精细化管理",
                        "进口替代"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药行业",
                        "政策影响"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}